Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Chondroitin Sulfate (CS) ELISA Kit-Competitive

Product Overview

BioVenic Canine Chondroitin Sulfate (CS) ELISA Kit-Competitive is designed for the quantitative determination of Canine Chondroitin Sulfate (CS) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.

Specifications

Assay Type ELISA-Competitive

Specificity The assay kit is specific for Canine CS.

Target Species Canine

Species Reactivity Canine

Detection Range 156.26-10000 pg/mL

Sensitivity 15.17 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 120 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Chondroitin sulfate (CS) is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars: N-acetylgalactosamine and glucuronic acid. It is usually found attached to proteins as part of a proteoglycan. Chondroitin sulfate is an important structural component of cartilage, providing much of its resistance to compression. Along with glucosamine, chondroitin sulfate is commonly used as a dietary supplement for the treatment of osteoarthritis. It is commonly used in dogs with osteoarthritis.

Target/Biomarker Canine CS

Target Synonym Chondroitin Sulfate

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Kampa, N. et al. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial. Front Vet Sci. 2023, 10: 1033188.